深圳市海普瑞药业集团股份有限公司（简称“深圳市海普瑞”，下同）于2026年1月5日公布截至2025年12月31日止的股份变动月报。报告显示，公司本月无新增股份发行或回购注销活动，股本保持稳定。
深圳市海普瑞目前在香港联合交易所有限公司上市的H股数目为220,094,500股，面值每股人民币1元，注册资本220,094,500元；于深圳证券交易所上市的A股数目为1,247,201,704股，面值每股人民币1元，注册资本1,247,201,704元。公司本月合计注册股本总额仍为人民币1,467,296,204元，未发生任何变动。
公告同时确认，公司遵守了香港联交所的上市规则及相关法律法规。该月报由联席公司秘书钱风奇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.